|
US5059591B1
(en)
|
1983-05-26 |
2000-04-25 |
Liposome Co Inc |
Drug preparations of reduced toxicity
|
|
US5571714A
(en)
|
1988-12-22 |
1996-11-05 |
Celtrix Pharmaceuticals, Inc. |
Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
|
|
US5731424A
(en)
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
|
US6124449A
(en)
|
1990-06-11 |
2000-09-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
|
US5731144A
(en)
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands
|
|
US5561163A
(en)
|
1990-08-31 |
1996-10-01 |
Deprenyl Animal Health, Inc. |
Treating hearing loss with deprenyl
|
|
US5421818A
(en)
|
1993-10-18 |
1995-06-06 |
Inner Ear Medical Delivery Systems, Inc. |
Multi-functional inner ear treatment and diagnostic system
|
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
|
US5837681A
(en)
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
|
US6593290B1
(en)
*
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
US6045528A
(en)
|
1997-06-13 |
2000-04-04 |
Intraear, Inc. |
Inner ear fluid transfer and diagnostic system
|
|
US6177434B1
(en)
|
1997-12-16 |
2001-01-23 |
The United States Of America As Represented By The Secretary Of The Navy |
Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
|
|
US6806358B1
(en)
|
1997-12-16 |
2004-10-19 |
University Of California San Diego |
Peptide inhibitor of TGF-β growth factors
|
|
WO1999043636A2
(en)
|
1998-02-27 |
1999-09-02 |
The United States Of America As Represented By Thesecretary Of The Department Of Health And Human Services |
Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
|
|
GB9809869D0
(en)
|
1998-05-09 |
1998-07-08 |
Medical Res Council |
Inhibition of protein kinases
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
ES2146552B1
(es)
|
1998-11-24 |
2001-04-16 |
Inst Cientifico Tecnol Navarra |
Peptidos inhibidores de tgf/31
|
|
AU4206200A
(en)
|
1999-04-05 |
2000-10-23 |
Adherex Technologies Inc. |
Compounds and methods for stimulating beta-catenin mediated gene expression and differentiation
|
|
US6492497B1
(en)
|
1999-04-30 |
2002-12-10 |
Cambridge Antibody Technology Limited |
Specific binding members for TGFbeta1
|
|
MXPA02011079A
(es)
|
2000-05-11 |
2004-08-19 |
Consejo Superior Investigacion |
Inhibidores heterociclicos de quinasa de sintasa de glucogeno gsk3.
|
|
US6509318B1
(en)
|
2000-09-29 |
2003-01-21 |
The Regents Of The University Of California |
TGF-B inhibitors and methods
|
|
US20050227936A1
(en)
|
2001-05-18 |
2005-10-13 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
|
US20050287128A1
(en)
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
|
EP1397364B1
(en)
|
2001-05-24 |
2007-07-25 |
Eli Lilly And Company |
Novel pyrrole derivatives as pharmaceutical agents
|
|
US20030028905A1
(en)
|
2001-07-31 |
2003-02-06 |
Petra Knaus |
Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms
|
|
MXPA04004178A
(es)
|
2001-11-01 |
2004-09-06 |
Janssen Pharmaceutica Nv |
Heteroarilaminas como inhibidores de glucogeno cintasa cinasa 3beta.
|
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
|
US20040006030A1
(en)
|
2002-07-02 |
2004-01-08 |
Isis Pharmaceuticals Inc. |
Antisense modulation of TGF-beta 2 expression
|
|
AU2003224335A1
(en)
|
2002-05-15 |
2003-12-02 |
Smithkline Beecham Corporation |
Benzoxazine and benzoxazinone substituted triazoles
|
|
EP1511738A4
(en)
|
2002-05-17 |
2007-05-09 |
Scios Inc |
TREATMENT OF FIBROPROLIFERATIVE DISEASES USING TGF BETA INHIBITORS
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
WO2004013135A1
(en)
|
2002-07-31 |
2004-02-12 |
Smithkline Beecham Corporation |
2-phenylpyridin-4-yl derivatives as alk5 inhibitors
|
|
EP1739087A1
(en)
|
2002-08-02 |
2007-01-03 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of gsk-3
|
|
DK1532145T3
(da)
|
2002-08-02 |
2007-01-15 |
Vertex Pharma |
Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
US7365066B2
(en)
|
2002-09-17 |
2008-04-29 |
Eli Lilly And Company |
Pyrazolopyridine derivatives as pharmaceutical agents
|
|
CA2497971A1
(en)
|
2002-09-18 |
2004-04-01 |
Pfizer Products Inc. |
Triazole derivatives as transforming growth factor (tgf) inhibitors
|
|
PL375973A1
(en)
|
2002-09-18 |
2005-12-12 |
Pfizer Products Inc. |
Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors
|
|
US20040138188A1
(en)
|
2002-11-22 |
2004-07-15 |
Higgins Linda S. |
Use of TGF-beta inhibitors to counteract pathologic changes in the level or function of steroid/thyroid receptors
|
|
CA2513140A1
(en)
|
2003-01-27 |
2004-08-12 |
Pfizer Products Inc. |
Isothiazole derivatives
|
|
ES2305744T3
(es)
|
2003-03-12 |
2008-11-01 |
Millennium Pharmaceuticals, Inc. |
Derivados de quinazolina como inhibidores e tgf-beta.
|
|
JP2006521398A
(ja)
|
2003-03-28 |
2006-09-21 |
サイオス・インコーポレーテツド |
ＴＧＦβの二−環式ピリミジン阻害剤
|
|
WO2004112710A2
(en)
|
2003-06-17 |
2004-12-29 |
Millennium Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
|
|
US20060229266A1
(en)
|
2003-08-13 |
2006-10-12 |
Kumar Nalin M |
Silencing of tgf-beta receptor type II expression by sirna
|
|
US7387614B2
(en)
|
2003-08-26 |
2008-06-17 |
University Of Maryland, Baltimore |
Drug delivery to the inner ear and methods of using same
|
|
WO2005039570A1
(ja)
|
2003-10-28 |
2005-05-06 |
Riken |
ＴＧＦ－β情報伝達経路阻害剤
|
|
US8673634B2
(en)
|
2003-11-13 |
2014-03-18 |
Massachusetts Eye & Ear Infirmary |
Method for the treatment of hearing loss
|
|
GB0327908D0
(en)
|
2003-12-02 |
2004-01-07 |
Neuropharma Sa |
GSK-3 inhibitors isolated from marine organisms
|
|
CN1921864A
(zh)
|
2003-12-24 |
2007-02-28 |
西奥斯公司 |
使用TGF－β抑制剂治疗神经胶质瘤
|
|
US7368445B2
(en)
|
2004-03-01 |
2008-05-06 |
Eli Lilly And Company |
Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
|
|
AR048335A1
(es)
|
2004-03-24 |
2006-04-19 |
Chugai Pharmaceutical Co Ltd |
Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
|
|
US8870826B2
(en)
|
2004-05-24 |
2014-10-28 |
Auris Medical Llc |
Combined otic aspirator and medication dispenser
|
|
GB0418328D0
(en)
|
2004-08-17 |
2004-09-22 |
Imp College Innovations Ltd |
Cancer methods and medicaments
|
|
JP2007176795A
(ja)
|
2004-08-18 |
2007-07-12 |
Univ Nihon |
ＴＧＦ−β遺伝子発現抑制剤
|
|
WO2006034207A2
(en)
|
2004-09-17 |
2006-03-30 |
Vanderbilt University |
Use of gsk3 inhibitors in combination with radiation therapies
|
|
WO2006086469A2
(en)
|
2005-02-08 |
2006-08-17 |
Genzyme Corporation |
Antibodies to tgfbeta
|
|
GB0505970D0
(en)
|
2005-03-23 |
2005-04-27 |
Univ Edinburgh |
Culture medium containing kinase inhibitor, and uses thereof
|
|
US20070066632A1
(en)
|
2005-03-25 |
2007-03-22 |
Scios, Inc. |
Fused bicyclic inhibitors of TGFbeta
|
|
CN103361301A
(zh)
|
2005-03-31 |
2013-10-23 |
斯丹姆涅恩有限公司 |
高度纯化来自羊膜的细胞群
|
|
WO2007003525A2
(en)
|
2005-06-30 |
2007-01-11 |
Janssen Pharmaceutica N.V. |
Cyclic anilino-pyridinotriazines as gsk-3 inhibitors
|
|
EP1910370B1
(en)
|
2005-07-22 |
2015-04-22 |
Eli Lilly And Company |
A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor
|
|
EP1749523A1
(en)
|
2005-07-29 |
2007-02-07 |
Neuropharma, S.A. |
GSK-3 inhibitors
|
|
CN101310012B
(zh)
|
2005-10-14 |
2012-05-09 |
明尼苏达大学董事会 |
非胚胎干细胞分化成具有胰腺表型的细胞
|
|
WO2007048857A1
(es)
|
2005-10-24 |
2007-05-03 |
Proyecto De Biomedicina Cima, S.L. |
USO DE PÉPTIDOS INHIBIDORES DE TGF- βl EN LA PREPARACIÓN DE UN AGENTE MODULADOR DE LA RESPUESTA INMUNE
|
|
US7951845B2
(en)
|
2006-01-19 |
2011-05-31 |
The Regents Of The University Of Michigan |
Composition and method of treating hearing loss
|
|
ITMI20060181A1
(it)
|
2006-02-03 |
2007-08-04 |
Univ Padova |
Modulatori del tgf-b e loro uso
|
|
TW200800203A
(en)
|
2006-03-08 |
2008-01-01 |
Astrazeneca Ab |
New use
|
|
US7846908B2
(en)
|
2006-03-16 |
2010-12-07 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of TGF-beta and therapeutic uses thereof
|
|
CA2650812C
(en)
|
2006-04-28 |
2017-12-12 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells
|
|
US20100292205A1
(en)
|
2006-08-23 |
2010-11-18 |
Pfizer Inc. |
Pyrimidone Compounds As GSK-3 Inhibitors
|
|
EP2094836B1
(en)
|
2006-11-15 |
2016-06-08 |
Massachusetts Eye & Ear Infirmary |
Generation of inner ear cells
|
|
CA2673368C
(en)
|
2006-12-19 |
2014-10-28 |
The Board Of Trustees Of The University Of Illinois |
3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
|
|
WO2009017453A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
New therapeutic combination of an antipsychotic and a gsk3 inhibitor 958
|
|
WO2009017455A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
A new combination of (a) an alpha-4-beta-2 -neuronal nicotinic agonist and (b) a gsk3 inhibitor
|
|
US20110190280A1
(en)
|
2007-08-29 |
2011-08-04 |
George Adjabeng |
Thiazole And Oxazole Kinase Inhibitors
|
|
US8377886B2
(en)
|
2007-09-14 |
2013-02-19 |
Albert Einstein College Of Medicine Of Yeshiva University |
Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease
|
|
SG188904A1
(en)
*
|
2008-03-17 |
2013-04-30 |
Scripps Research Inst |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
|
KR20130097813A
(ko)
*
|
2008-04-21 |
2013-09-03 |
오토노미, 인코포레이티드 |
귀 질환 및 병태를 치료하기 위한 귀 조제물
|
|
US20090270497A1
(en)
|
2008-04-24 |
2009-10-29 |
Pharmacyclics, Inc. |
Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
|
|
US8822410B2
(en)
|
2008-05-19 |
2014-09-02 |
Children's Medical Center Corporation |
Tympanic membrane permeating ear drops and uses thereof
|
|
WO2010011466A2
(en)
|
2008-06-27 |
2010-01-28 |
Otonomy, Inc. |
Controlled-release cns modulating compositions and methods for the treatment of otic disorders
|
|
US8496957B2
(en)
|
2008-07-21 |
2013-07-30 |
Otonomy, Inc |
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
US20120059021A1
(en)
*
|
2008-11-11 |
2012-03-08 |
University Of Washington |
Compositions and methods for treating cancer and methods for predicting a response to such treatments
|
|
WO2010060088A2
(en)
*
|
2008-11-24 |
2010-05-27 |
Massachusetts Eye & Ear Infirmary |
Pathways to generate hair cells
|
|
US9045737B2
(en)
|
2008-12-13 |
2015-06-02 |
Dnamicroarray, Inc. |
Artificial three-dimensional microenvironment niche culture
|
|
WO2010075551A1
(en)
|
2008-12-24 |
2010-07-01 |
Massachusetts Institute Of Technology |
Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorder
|
|
ES2579909T3
(es)
|
2009-02-03 |
2016-08-17 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Medio de cultivo para células madre epiteliales y organoides que comprenden dichas células madre
|
|
EP2412800A1
(en)
*
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
|
GB201111244D0
(en)
|
2011-06-30 |
2011-08-17 |
Konink Nl Akademie Van Wetenschappen Knaw |
Culture media for stem cells
|
|
US9752124B2
(en)
|
2009-02-03 |
2017-09-05 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising the stem cells
|
|
BRPI1008974A2
(pt)
|
2009-03-11 |
2017-06-06 |
Kyorin Seiyaku Kk |
composto, composição farmacêutica, e, método para tratar, prevenir ou melhorar uma doença mediada com gsk-3
|
|
WO2011019957A1
(en)
|
2009-08-12 |
2011-02-17 |
University Of Southern California |
Method for formation of induced pluripotent stem cells
|
|
CA2779310C
(en)
|
2009-10-31 |
2021-11-30 |
New World Laboratories Inc. |
Methods for reprogramming cells and uses thereof
|
|
US20110135756A1
(en)
|
2009-12-08 |
2011-06-09 |
University Of Washington |
Compositions and methods for protecting sensory hair cells
|
|
DE112010005017A5
(de)
|
2009-12-28 |
2012-10-04 |
Audiocure Pharma Gmbh |
Beta-carboline zur behandlung von hörschäden und schwindel
|
|
WO2011089416A1
(en)
|
2010-01-19 |
2011-07-28 |
Astrazeneca Ab |
Pyrazine derivatives
|
|
EP2550355B1
(en)
|
2010-03-22 |
2016-11-16 |
Takara Bio Europe AB |
Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of wnt-signalling pathway
|
|
CA2800498C
(en)
|
2010-03-31 |
2021-11-16 |
The Scripps Research Institute |
Reprogramming cells
|
|
CN103429739B
(zh)
|
2010-05-12 |
2018-11-13 |
哥伦比亚大学纽约管理委员会 |
制备产生和分泌胰岛素的肠内分泌细胞的方法
|
|
EP2636731B1
(en)
|
2010-11-02 |
2016-07-13 |
National University Corporation Kumamoto University |
Method of producing intestinal cells
|
|
EP2667881A4
(en)
|
2011-01-24 |
2015-04-22 |
Univ Leland Stanford Junior |
METHOD FOR IN VITRO GENERATION OF INTERNAL CELLS
|
|
KR101807704B1
(ko)
|
2011-04-12 |
2017-12-13 |
차의과학대학교 산학협력단 |
역분화-증진제를 이용한 역분화 만능 줄기세포의 제조방법
|
|
EP3473099A1
(en)
*
|
2011-09-14 |
2019-04-24 |
Samumed, LLC |
Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
|
JP6041270B2
(ja)
|
2011-10-06 |
2016-12-07 |
学校法人慶應義塾 |
角膜内皮細胞の製造方法
|
|
ES2632428T3
(es)
|
2012-02-24 |
2017-09-13 |
Asd Therapeutics Partners Llc |
Nuevas tiadiazolidinadionas como inhibidores de GSK-3
|
|
US9457009B2
(en)
|
2012-05-31 |
2016-10-04 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Methods and compositions for preventing and treating auditory dysfunctions
|
|
TW201406758A
(zh)
|
2012-06-28 |
2014-02-16 |
Daiichi Sankyo Co Ltd |
三環性化合物
|
|
GB201212960D0
(en)
|
2012-07-20 |
2012-09-05 |
Common Services Agency |
Erythroid production
|
|
CA2884309A1
(en)
*
|
2012-09-07 |
2014-03-13 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity
|
|
TW201417817A
(zh)
|
2012-09-25 |
2014-05-16 |
Daiichi Sankyo Co Ltd |
Ｇｓｋ３抑制劑與抗ｄｒ５抗體之組合
|
|
JP6321662B2
(ja)
|
2012-10-12 |
2018-05-09 |
ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. |
Ｇｓｋ３阻害剤およびその使用の方法
|
|
WO2014083132A1
(en)
|
2012-11-29 |
2014-06-05 |
Cellectis Sa |
Maturation of hepatocyte-like cells derived from human pluripotent stem cells
|
|
US20140248696A1
(en)
|
2013-03-01 |
2014-09-04 |
Wisconsin Alumni Research Foundation |
Methods of maintaining, expanding, and diffrentiating neuronal subtype specific progenitors
|
|
LT2970890T
(lt)
*
|
2013-03-14 |
2020-07-10 |
The Brigham And Women`S Hospital, Inc. |
Kompozicijos ir būdai, skirti epitelinių kamieninių ląstelių padauginimui ir kultivavimui
|
|
WO2015168149A2
(en)
|
2014-04-28 |
2015-11-05 |
Massachusetts Eye & Ear Infirmary |
Sensorineural hair cell differentiation
|
|
US10457915B2
(en)
|
2014-05-15 |
2019-10-29 |
International Stem Cell Corporation |
Chemical differentiation of pluripotentstem cells into retinal epithelial cells
|
|
WO2016037016A1
(en)
|
2014-09-03 |
2016-03-10 |
The Brigham And Women's Hospital, Inc. |
Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
|
|
CN104726395B
(zh)
|
2015-03-20 |
2018-03-23 |
深圳市人民医院 |
一种诱导人诱导多能干细胞定向分化为胰腺细胞的方法
|
|
GB201505605D0
(en)
|
2015-03-31 |
2015-05-13 |
Univ Sheffield |
Method for producing otic progenitors
|
|
WO2017048193A1
(en)
|
2015-09-15 |
2017-03-23 |
Agency For Science, Technology And Research (A*Star) |
Derivation of liver organoids from human pluripotent stem cells
|
|
CN108779437A
(zh)
|
2016-01-08 |
2018-11-09 |
麻省理工学院 |
分化的肠内分泌细胞和胰岛素产生细胞的制备
|
|
WO2019183572A1
(en)
|
2018-03-23 |
2019-09-26 |
Refuge Biotechnologies, Inc. |
Gene regulation via conditional nuclear localization of gene modulating polypeptides
|